The design of SeeSAR has changed a lot and many new features – like multi-protein handling – have been implemented. This webinar shall give you an update of the recent changes and guide you through...
To define, in which binding site SeeSAR should calculate the qualitative affinity, you can either select a co-crystalized compound, or an allosteric or apo site, calculated with the integrated DogS...
SeeSAR is a software tool for interactive, visual compound prioritization as well as compound evolution. This video provides a brief tutorial-style introduction.
The affinity prediction method within SeeSAR is well able to explain very steep activity cliffs. We demonstrate this on the basis of a classical magic methyl case of a p38 Map Kinase as discovered ...
The question of whether toxicity caused by small molecules is due to on-target or off-target pharmacological effects is frequently encountered in drug discovery programs and of decision making sign...
p38α mitogen-activated protein kinase (MAPK) is an important molecular switch involved in the regulation of many pathways, such as pro-inflammatory signaling networks and cytokines biosynthesis. A ...
From the outset, Astex have committed to developing a highly integrated informatics platform for fragment-based drug discovery. This ensures scientists from all disciplines have all relevant data a...
The remit of MRC Technology, a charity and small biotech, is to help accelerate the process of target validation and generating tool compounds for enabling further exploration of new targets (as pr...
Structure-based ligand design is an integral part of modern drug discovery. However, depending on how established a target is, different challenges arise. An example for targets with little present...
Many medicinal chemistry-relevant structures and core scaffolds tend toward geometric planarity, which hampers the optimization of physicochemical properties desirable in drug-like molecules. As ch...
Carbohydrates represent the most abundant class of molecules in nature and are involved in inflammation, cancer, and infectious disease. Consequently, the design of molecules that mimic structural ...
Chemical fragment spaces consist of molecular fragments and corresponding connection rules. The introduction of this talk deals with the question why searches in chemical fragment spaces are valuab...
Our successful beginners' webinar about docking, i.e., "Getting the ligand in" from 2015 reached more than 3.000 viewers. In this webinar with an Asia-compatible timing, we update everyone with a s...
How to use the amazing new ReCore sneak preview rescaffolding machinery in SeeSAR 5.1. Protein clash filtering, pharmacophore etc - all this to be added soon.
In this webinar we will show you two exciting applications using SeeSAR. Two strategies for novel inhibitors against Bruton's Tyrosine Kinase, one by Takeda and one by Genentech. Both examples bene...
With the public availability of large integrated data sources such as the Open PHACTS Discovery Platform, retrieval of data sets for certain protein targets of interest measured under consistent as...
Make the most of your SeeSAR installation! This webinar will guide you through the most important problem-solving features of the popular medicinal chemistry software SeeSAR. Since the advent of AD...
No matter how big your in-house library and no matter how many compounds you acquire as supplement, it merely scratches the surface of what chemists are capable of synthesizing. Recent publications...
Today's drug discovery pipelines are under a lot of pressure. Although in the past years (since 2010) the approval rate of the FDA has slightly increased, pharma companies are still searching for w...
Join us for a highly instructive webinar on ADME modeling in compound design. Optibrium's CEO, Dr. Matt Segall, will introduce you into the development and validation of quantitative structure-acti...
Edelris has pioneered for the past decade the design and synthesis of innovative, natural product-like small molecules (Keymical Collections(TM)) and generated its own Keymical Space(TM) representi...
This talk will give an overview of the importance of scaffold hopping in practical medicinal chemistry applications. It will introduce the relevance of the topic and potential pitfalls by means of ...
Nearly every structure-based molecular design endevour starts with a crystal structure, however, the path from raw PDB files to the input necessary for detailled molecular modelling is not always o...
1/3 of marketed drugs are covalent binders. Use SeeSAR to increase your drug’s target occupancy for more effective treatment! http://www.biosolveit.de/SeeSAR
SeeSAR enables you to manually select water molecules to be either conserved (clash test still applies) or to be excluded from the active site. http://www.biosolveit.de/SeeSAR
"We tend to believe that PDB files are a message from God." — This recent statement from blogger and Vertex scientist Dr. Derek Lowe ironically captures the danger of getting lost in false assumpti...
Imagine all data about compounds and their related biological targets were easily accessible in on just one web-interface. ChemBioNavigator (CBN) is such a web-application that was specifically des...
"Leave modeling to the experts!" — Today's working conditions put pressure on this mantra: Research must live with less workforce and faster results are expected; on the other hand, new algorithms,...
Predicting binding affinity is still regarded as the holy grail. With SeeSAR, however, we are one step closer to accurately and reliably predict a protein-ligand's binding affinity. What one often ...
The synthesis of target focused libraries is a core task in medicinal chemistry. In this webinar we will demonstrate how you can use your protein structure(s) to help select optimal commercially av...
Drug Discovery is a multi-faceted, multi-parameter optimization problem. A big pain in the process is that there is no one solution for everything. The result is a tremendous loss in efficiency. Ph...
With today's pharma projects under increased pressure, it is necessary to put more emphasis on how the medicinal chemists can be helped achieve their goals faster. Given the vast amount of compound...
Computational tools are invaluable in the process of identifying high-quality fragment hits. In this one hour BioSolveIT webinar you will learn how to fast-track your fragment hit discovery using o...
Did you know that shaving two months off the Hit2Lead/LeadOpt phase can save you about $10m? Let us introduce you to a whole new way of leveraging MedChem know-how early on in the CADD phase and th...
BioSolveIT offers a comprehensive suite of world-leading products covering structure-based, ligand-based and fragment-based design. But did you know that through the intuitive Pipeline Pilot® inter...
Computational tools are invaluable in the process of identifying fragment hits. In this one hour BioSolveIT webinar you will initially learn how to fast-track your fragment hit discovery, and by th...
Drug discovery is like fighting the Hydra: One challenge mastered means 9 more to come. No one software can handle them all. However, workflow systems like KNIME® offer you a single interface to a ...
Turning early stage discoveries in cell and molecular biology into small molecule tool compounds and drug-like leads is a significant challenge, especially when resources are limited. We will show ...
In this one hour webinar, discover how you can enhance productivity in hit-2-lead/LO by leveraging MedChem know-how early on in the CADD phase and thus reduce cycle times and costs. We showcase Lea...
"But we don't have a protein structure!" – it's a common complaint in drug hunting. In fact, you don't have your back to the wall if you need to spot active compounds in this situation! In this Bio...
"Getting the ligand in" is a ubiquitous task in early drug hunting. However, with the right tools it is not that hard. We will show you how, help you avoid the common pitfalls, and demonstrate how ...
47 seconds introducing you into basic L.O. with SeeSAR. See how quickly you can exchange an "unhappy" oxygen atom versus a sulfur - eventually gaining affinity.